Lọc theo
Replacing saturated fatty acid (SFA) with unsaturated fatty acids, particularly from plant sources, and eliminating dietary trans fatty acid (TFA) can help prevent premature death, according to a study.
A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels may predict the incidence of cardiovascular events over a 30-year period, as shown in a study.
The use of noncigarette tobacco products is associated with distinctive cardiovascular outcomes, including stroke for cigar, heart failure for pipe, and total cardiovascular disease (CVD) for smokeless tobacco, as shown in a study.
Intensive blood-pressure (BP) lowering treatment targeted at a tighter systolic BP (SBP) yields cardiovascular benefits in Chinese patients with type 2 diabetes (T2D) and elevated BP in the randomized BPROAD* trial.
Treatment with the potassium binder sodium zirconium cyclosilicate (SZC) stabilizes potassium levels in patients with heart failure with reduced ejection fraction (HFrEF) during spironolactone optimization, as shown in the prospective, randomized-withdrawal REALIZE-K trial.
Coffee’s beneficial effect on mortality may be time-dependent, with a study showing a strong association between lower mortality risk and coffee consumed in the morning.
Monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) or its receptor do not appear to contribute to heightened risk of cardiovascular disease (CVD) relative to onabotulinumtoxinA in adults with migraine at high CVD risk, according to a study.
The small-interfering RNA zerlasiran appears promising in the treatment of patients with atherosclerotic cardiovascular disease (ASCVD), reducing time time-averaged lipoprotein(a) concentration by more than 80 percent over 36 weeks of follow-up, as shown in a phase II trial.
Treatment with the allosteric cardiac myosin inhibitor mavacamten in severely symptomatic patients with obstructive HCM allows for the deferral of invasive SRT for nearly 2.5 years, as shown in the end-of-trial results of VALOR-HCM presented at AHA 2024
Vitamin D may protect against young-onset ischaemic stroke through preventing atrial fibrillation (AF), a University of Hong Kong (HKU) study on Southern Chinese has found.
